Modafinil-Quetiapine Drug Interaction
Yes, there is a clinically significant pharmacokinetic interaction between modafinil and quetiapine (Seroquel) that reduces quetiapine blood levels by approximately 29%. 1
The Interaction Mechanism
Modafinil acts as an enzyme inducer that increases the metabolism of quetiapine, resulting in substantially decreased systemic exposure. According to FDA labeling data, concomitant administration of armodafinil (the R-enantiomer of modafinil) 250 mg with quetiapine (300-600 mg daily) resulted in a reduction in mean systemic exposure of quetiapine by approximately 29% 1. This occurs through modafinil's induction of hepatic enzymes, particularly CYP3A4, which is the primary metabolic pathway for quetiapine.
Clinical Implications for Your Narcolepsy Patient
If your patient requires both medications, you will need to increase the quetiapine dose to maintain therapeutic efficacy. The interaction is bidirectional in its clinical impact:
- Reduced quetiapine efficacy: The 29% reduction in quetiapine exposure means whatever psychiatric indication quetiapine is treating (psychosis, bipolar disorder, depression augmentation, or insomnia) may become inadequately controlled
- Modafinil remains appropriate: Modafinil is a STRONG recommendation for narcolepsy treatment 2
Management Algorithm
If quetiapine is essential: Increase the quetiapine dose by approximately 30-40% when initiating modafinil, monitoring for return of psychiatric symptoms or loss of therapeutic effect
Monitor closely: Watch for breakthrough psychiatric symptoms (hallucinations, delusions, mood instability, or insomnia depending on indication) within 1-2 weeks of starting modafinil
Consider alternatives if feasible:
- For narcolepsy: Other strong recommendations include pitolisant, sodium oxybate, or solriamfetol 2
- For the quetiapine indication: Consider medications without significant CYP3A4 metabolism if the psychiatric condition allows
Dose timing: Administer modafinil in the morning (as recommended for narcolepsy) and quetiapine at bedtime to minimize overlapping peak concentrations, though this does not eliminate the interaction
Important Caveats
- This interaction is pharmacokinetic (affecting drug levels) rather than pharmacodynamic (affecting drug effects at receptors), making it predictable and manageable through dose adjustment
- The interaction persists as long as both medications are used together
- If modafinil is discontinued, quetiapine levels will rise over 1-2 weeks, potentially causing excessive sedation or other adverse effects—requiring quetiapine dose reduction back to baseline
- No evidence suggests this combination increases safety risks beyond the expected reduction in quetiapine efficacy
The evidence for this interaction comes directly from FDA drug labeling based on formal pharmacokinetic studies, making it high-quality, definitive information that should guide prescribing decisions 1.